Search Result

All Related Services Other Content

LNP Formulation Services
Analytical & Characterization Services
Early-Phase Manufacturing
Catalogue Products
Small Molecule Solid Form CRO Services and Formulation CDMO Services
Solid-State Characterization/FAST Our Solid State Characterization Service, which is referred to as Focused Analytical Solids Testing (FAST), covers many routine analyses encountered during pharmaceutical development. The FAST concept is directly aligned with our goal of partnering with organizations instead of merely providing data.
Conventional Oral Solid Dosage Forms Oral solid dosage forms are an important part of the global pharmaceutical market, accounting for most of the small molecule pharmaceutical market, of which tablets and capsules are the most common dosage forms. With the vigorous development of domestic and foreign innovative drugs and the rise of global Biotech, its asset-light and R&D-focused development model will choose more outsourcing forms.
Our History Founded in 2010, Crystal Pharmatech has been recognized as the leading technology-driven contract research organization (CRO) in solid-state research, crystallization process development, and preformu...
News
Our Business
Case Study 2: DPC 961 – Form Change On A Fast Track Compound DPC 961 (Fig. 6) was a development compound indicated for the treatment of HIV infections and was developed as a neutral molecule (Staszewski et al. 1999). The compound was designated as Biopharmaceut...
Bioanalysis and Biomarker Services With more than 100 years of combined industry experience of our leadership team and GLP compliant laboratories, we are ready for all your current and emerging bioanalytical needs.BioactivityImmunoassa...
Mol2Med™ First-Time-Right Approach Streamlining the Design and Development of First-Time-Right Crystal Forms and Formulations for Advancing Small Molecules to Phase I and Beyond
Developability Assessment For lead compounds or candidate compounds, Crystal pharmatech can make an objective evaluation of the development potential and risks of drugs through comprehensive and accurate evaluation of the physicochemical properties of compounds, combined with a variety of mature development evaluation models and GastroPlus^® software.